Antibe Therapeutics Inc. (ATBPF)
USD 0.22
(0.19%)
USD 0.22
(0.19%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 70.56 Million CAD | -20.86% |
| 2022 | 89.15 Million CAD | 9.07% |
| 2021 | 81.74 Million CAD | 490.7% |
| 2020 | 13.83 Million CAD | -6.62% |
| 2019 | 14.81 Million CAD | 18.64% |
| 2018 | 12.49 Million CAD | 16.46% |
| 2017 | 10.72 Million CAD | 10.12% |
| 2016 | 9.74 Million CAD | 1133.99% |
| 2015 | 789.32 Thousand CAD | -81.86% |
| 2014 | 4.35 Million CAD | 489.61% |
| 2013 | 738.02 Thousand CAD | 331.98% |
| 2012 | 170.84 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 66.83 Million CAD | -5.28% |
| 2024 Q3 | 56.36 Million CAD | -6.38% |
| 2024 Q2 | 60.2 Million CAD | -9.92% |
| 2023 Q2 | 79.17 Million CAD | -5.17% |
| 2023 Q3 | 73.72 Million CAD | -6.87% |
| 2023 FY | 70.56 Million CAD | -20.86% |
| 2023 Q4 | 70.56 Million CAD | -4.3% |
| 2023 Q1 | 83.48 Million CAD | -6.36% |
| 2022 Q4 | 89.15 Million CAD | -3.58% |
| 2022 Q3 | 92.46 Million CAD | -3.54% |
| 2022 FY | 89.15 Million CAD | 9.07% |
| 2022 Q2 | 95.85 Million CAD | -6.81% |
| 2022 Q1 | 102.85 Million CAD | 25.83% |
| 2021 Q2 | 29.74 Million CAD | -23.4% |
| 2021 Q4 | 81.74 Million CAD | 233.39% |
| 2021 FY | 81.74 Million CAD | 490.7% |
| 2021 Q1 | 38.82 Million CAD | 180.59% |
| 2021 Q3 | 24.51 Million CAD | -17.57% |
| 2020 Q1 | 12.89 Million CAD | -13.0% |
| 2020 FY | 13.83 Million CAD | -6.62% |
| 2020 Q4 | 13.83 Million CAD | -9.06% |
| 2020 Q3 | 15.21 Million CAD | -12.58% |
| 2020 Q2 | 17.4 Million CAD | 35.0% |
| 2019 Q4 | 14.81 Million CAD | 20.83% |
| 2019 Q1 | 13.01 Million CAD | 4.21% |
| 2019 Q3 | 12.26 Million CAD | 1.18% |
| 2019 FY | 14.81 Million CAD | 18.64% |
| 2019 Q2 | 12.12 Million CAD | -6.89% |
| 2018 Q3 | 10.33 Million CAD | -14.02% |
| 2018 FY | 12.49 Million CAD | 16.46% |
| 2018 Q2 | 12.02 Million CAD | -7.31% |
| 2018 Q4 | 12.49 Million CAD | 20.81% |
| 2018 Q1 | 12.97 Million CAD | 20.95% |
| 2017 FY | 10.72 Million CAD | 10.12% |
| 2017 Q3 | 11.08 Million CAD | 13.05% |
| 2017 Q4 | 10.72 Million CAD | -3.26% |
| 2017 Q1 | 10.61 Million CAD | 8.96% |
| 2017 Q2 | 9.8 Million CAD | -7.59% |
| 2016 Q3 | 9.92 Million CAD | 1054.55% |
| 2016 Q4 | 9.74 Million CAD | -1.89% |
| 2016 Q2 | 859.87 Thousand CAD | -44.12% |
| 2016 Q1 | 1.53 Million CAD | 94.96% |
| 2016 FY | 9.74 Million CAD | 1133.99% |
| 2015 FY | 789.32 Thousand CAD | -81.86% |
| 2015 Q3 | 1.24 Million CAD | -48.64% |
| 2015 Q2 | 2.41 Million CAD | -29.29% |
| 2015 Q1 | 3.41 Million CAD | -21.44% |
| 2015 Q4 | 789.32 Thousand CAD | -36.42% |
| 2014 Q2 | 1.83 Million CAD | -9.73% |
| 2014 Q4 | 4.35 Million CAD | 119.49% |
| 2014 Q3 | 1.98 Million CAD | 7.89% |
| 2014 FY | 4.35 Million CAD | 489.61% |
| 2014 Q1 | 2.03 Million CAD | 175.8% |
| 2013 FY | 738.02 Thousand CAD | 331.98% |
| 2013 Q4 | 738.02 Thousand CAD | 0.0% |
| 2012 FY | 170.84 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| IR-Med Inc. | 999 Thousand USD | -6963.163% |
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 144.38 Thousand USD | -48769.02% |
| Medical Supply International USA, Inc. | 870.77 Thousand USD | -8003.279% |
| Polarean Imaging plc | 10.86 Million USD | -549.299% |
| Avitar, Inc. | 1.74 Million USD | -3937.075% |
| AVITA Medical, Inc. | 144.33 Million USD | 51.115% |
| Manhattan Scientifics, Inc. | 316 Thousand USD | -22229.43% |
| Össur hf. | 1.39 Billion USD | 94.938% |
| Zecotek Photonics Inc. | 2.57 Million USD | -2642.477% |
| QHSLab, Inc. | 1.68 Million USD | -4096.483% |
| Wellstar International, Inc. | 957.89 Thousand USD | -7266.279% |
| Össur hf. | 1.39 Billion USD | 94.938% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 102.92 Million USD | 31.441% |
| Escalon Medical Corp. | 4.75 Million USD | -1383.02% |
| Aurora Spine Corporation | 11.92 Million USD | -491.768% |
| BrainsWay Ltd. | 62.97 Million USD | -12.051% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 2.85 Million USD | -2373.174% |
| Hamilton Thorne Ltd. | 110.16 Million USD | 35.949% |
| Vivos Inc. | 1.61 Million USD | -4282.333% |
| MicroPort Scientific Corporation | 3.93 Billion USD | 98.205% |
| Kelyniam Global, Inc. | 1.63 Million USD | -4221.753% |
| REMSleep Holdings, Inc. | 1.2 Million USD | -5749.306% |
| CYduct Diagnostics, Inc. | 54.74 Thousand USD | -128783.247% |
| Nanomix Corporation | 982.05 Thousand USD | -7085.035% |
| Theraclion SA | 18.66 Million EUR | -278.068% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 182.18 Thousand USD | -38631.474% |
| Positron Corporation | 1.76 Million USD | -3891.797% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 748.38 Thousand USD | -9328.461% |
| Lombard Medical, Inc. | 67.76 Million USD | -4.123% |
| ALR Technologies Inc. | 193.21 Thousand USD | -36419.043% |
| Stratec SE | 529.71 Million USD | 86.679% |
| Vycor Medical, Inc. | 992.29 Thousand USD | -7010.868% |
| Heart Tronics, Inc. | 4.04 Million USD | -1642.705% |
| Nu-Med Plus, Inc. | 2.21 Million USD | -3089.868% |
| Perimeter Medical Imaging AI, Inc. | 20.54 Million USD | -243.507% |
| SANUWAVE Health, Inc. | 22.41 Million USD | -214.78% |
| VMS Rehab Systems, Inc. | 4.45 USD | -1585640349.438% |
| Guided Therapeutics, Inc. | 1.66 Million USD | -4127.741% |
| Ingen Technologies, Inc. | 737.73 Thousand USD | -9464.507% |
| Odyssey Group International, Inc. | 455.79 Thousand USD | -15380.931% |
| United American Healthcare Corporation | 10.37 Million USD | -579.844% |
| ECGI Holdings, Inc. | 5.2 Million USD | -1256.575% |
| Capital Group Holdings, Inc. | 33.79 Thousand USD | -208697.42% |
| ADM Tronics Unlimited, Inc. | 2.13 Million USD | -3199.204% |
| Urologix, Inc. | 5.66 Million USD | -1145.121% |
| Rapid Therapeutic Science Laboratories, Inc. | 2.25 Million USD | -3029.674% |
| Nexeon MedSystems Inc. | 20.35 Million USD | -246.712% |
| SS Innovations International, Inc. | 25.47 Million USD | -176.937% |
| Qualis Innovations, Inc. | 2431.00 USD | -2902450.391% |
| Smith & Nephew plc | 9.97 Billion USD | 99.292% |
| NIOX Group Plc | 116.47 Million USD | 39.422% |
| Fuse Medical, Inc. | 16.25 Million USD | -333.977% |
| Broncus Holding Corporation | 195.75 Million USD | 63.954% |
| Brain Scientific Inc. | 11.74 Million USD | -500.845% |
| Pressure BioSciences, Inc. | 1.04 Million USD | -6622.17% |
| Health Logic Interactive Inc. | 28.73 Thousand USD | -245457.682% |